menu
    • menu

    Company profile for GRI Bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GRI Bio is a clinical stage biotech company focused on fundamentally changing the way inflammatory disease is treated by targeting NKT immune cells earlier in the inflammatory chain to interrupt disease progression more effectively. GRI Bio’s lead program, GRI-0621, is a small molecule RAR-βɣ dual agonist that inhibits the activity of human Type 1 invariant NKT (iNKT) cells, returning the immune system to homeostasis. Oral...
    GRI Bio is a clinical stage biotech company focused on fundamentally changing the way inflammatory disease is treated by targeting NKT immune cells earlier in the inflammatory chain to interrupt disease progression more effectively. GRI Bio’s lead program, GRI-0621, is a small molecule RAR-βɣ dual agonist that inhibits the activity of human Type 1 invariant NKT (iNKT) cells, returning the immune system to homeostasis. Oral dosing of GRI-0621 has been shown to inhibit iNKT cells in patients and improve fibrosis in multiple disease models.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GRI BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2223 Avenida De La Playa Ste 208, La Jolla, California, 92037
    Telephone
    Telephone
    (619) 400-1171
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gribio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GRI Bio Announces Closing Of $8.0 Million Public Offering
    GRI Bio Announces Closing Of $8.0 Million Public Offering

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204858/0/en/GRI-Bio-Announces-Closing-of-8-0-Million-Public-Offering.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    GRI Bio Announces Pricing Of $8,000,000 Million Public Offering
    GRI Bio Announces Pricing Of $8,000,000 Million Public Offering

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3204000/0/en/GRI-Bio-Announces-Pricing-of-8-000-000-Million-Public-Offering.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    GRI Touts IPF Safety Edge, Lung Function Gains Amid Cash Crunch
    GRI Touts IPF Safety Edge, Lung Function Gains Amid Cash Crunch

    11 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gri-touts-ipf-safety-edge-lung-function-gains-amid-cash-crunch

    FIERCE BIOTECH
    11 Dec 2025
    Share Share
    GRI Bio: Positive Topline Data from Phase 2a IPF Study
    GRI Bio: Positive Topline Data from Phase 2a IPF Study

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203497/0/en/GRI-Bio-Announces-Positive-Topline-Data-from-its-Phase-2a-Study-in-Idiopathic-Pulmonary-Fibrosis-IPF.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    GRI Bio Reveals 6-Week Lung Function Data in Phase 2a IPF Study
    GRI Bio Reveals 6-Week Lung Function Data in Phase 2a IPF Study

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148561/0/en/GRI-Bio-Reports-6-Week-Interim-Lung-Function-Data-in-Ongoing-Phase-2a-Study-in-Idiopathic-Pulmonary-Fibrosis-IPF.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Gri Bio to Present at H.C. Wainwright Global Conference
    Gri Bio to Present at H.C. Wainwright Global Conference

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143682/0/en/GRI-Bio-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search